Search research articles
Contact Us
Filters
Showing results (831-840 of 968) with videos related to
Page
of 97
Sort By:
Ebiomedicine
|
August 7, 2023
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype
Heidi Fettke, Chao Dai, Edmond M Kwan, et al.
Neurobiology of Disease
|
January 14, 2015
Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice
Bibiana K Y Wong, Dagmar E Ehrnhoefer, Rona K Graham, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML
James M Kelvin, Juhi Jain, Aashis Thapa, et al.
Human Molecular Genetics
|
June 19, 2003
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, et al.
Oncogene
|
May 3, 2006
Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase
A K Keating, D B Salzberg, S Sather, et al.
Contemporary Clinical Trials
|
February 14, 2021
Harnessing mobile technology to reduce mental health disorders in college populations: A randomized controlled trial study protocol
Ellen E Fitzsimmons-Craft, C Barr Taylor, Michelle G Newman, et al.
The Journal of Pathology
|
September 10, 2017
MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer
Javier A Baena-Del Valle, Qizhi Zheng, David M Esopi, et al.
Nature Reviews. Urology
|
November 1, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
Joakin O Mori, Isra Elhussin, W Nathaniel Brennen, et al.
Body Image
|
December 13, 2021
Psychometric properties of the Perceived Benefits of Thinness Scale in college-aged women
Rachael E Flatt, Anna M Karam, Ellen E Fitzsimmons-Craft, et al.
Journal of Medicinal Chemistry
|
April 11, 2025
Discovery of Novel TYRO3/MERTK Dual Inhibitors
Deyu Kong, Jichen Zhao, Daowei Huang, et al.
Page
of 97
Search research articles
Search
Showing results (831-840 of 968) with videos related to
Sort By:
Page
of 97
Ebiomedicine
|
August 7, 2023
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype
Heidi Fettke, Chao Dai, Edmond M Kwan, et al.
Neurobiology of Disease
|
January 14, 2015
Partial rescue of some features of Huntington Disease in the genetic absence of caspase-6 in YAC128 mice
Bibiana K Y Wong, Dagmar E Ehrnhoefer, Rona K Graham, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML
James M Kelvin, Juhi Jain, Aashis Thapa, et al.
Human Molecular Genetics
|
June 19, 2003
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, et al.
Oncogene
|
May 3, 2006
Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase
A K Keating, D B Salzberg, S Sather, et al.
Contemporary Clinical Trials
|
February 14, 2021
Harnessing mobile technology to reduce mental health disorders in college populations: A randomized controlled trial study protocol
Ellen E Fitzsimmons-Craft, C Barr Taylor, Michelle G Newman, et al.
The Journal of Pathology
|
September 10, 2017
MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer
Javier A Baena-Del Valle, Qizhi Zheng, David M Esopi, et al.
Nature Reviews. Urology
|
November 1, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
Joakin O Mori, Isra Elhussin, W Nathaniel Brennen, et al.
Body Image
|
December 13, 2021
Psychometric properties of the Perceived Benefits of Thinness Scale in college-aged women
Rachael E Flatt, Anna M Karam, Ellen E Fitzsimmons-Craft, et al.
Journal of Medicinal Chemistry
|
April 11, 2025
Discovery of Novel TYRO3/MERTK Dual Inhibitors
Deyu Kong, Jichen Zhao, Daowei Huang, et al.
Page
of 97